Company News in the Life Science Industry

SHANGHAI, Aug. 13, 2020 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO") (SHSE: 688185, HKEX:06185) announced today that it has successfully listed on the Sci-Tech Innovation Board (STAR Market) of the Shanghai Stock Exchange, making it the first "A+ H" dual listing vaccine company. CanSinoBIO... Read more ››

BRISBANE, Australia, Aug. 12, 2020 /PRNewswire/ -- QBiotics Group Limited (QGL), a life sciences company developing novel anticancer and wound healing pharmaceuticals, is pleased to announce that it has entered into an agreement with MSD (tradename of Merck & Co., Inc., Kenilworth, NJ, USA),... Read more ››

MILWAUKEE, Aug. 12, 2020 /PRNewswire/ -- Serve You Rx President and Chief Executive Officer Sharon Murillo will join Ryan Hampton, author of "The American Fix" and founder of The Voices Project, in kicking off the national Mobilize Recovery virtual event being held Aug. 18 - 20, 2020. Mobilize... Read more ››

EAST HANOVER, N.J., Aug. 13, 2020 /PRNewswire/ -- Novartis today announced that the US Food and Drug Administration (FDA) accepted the company's supplemental Biologics License Application (sBLA) for a new self-administration option for Xolair(®) (omalizumab) across all approved US indications.... Read more ››

SHANGHAI and MELBOURNE, Australia, Aug. 13, 2020 /PRNewswire/ -- Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company, announced today the authorization of the first-in-human trial of ATG-017 (ERASER trial) by the Australian Therapeutic Goods Administration... Read more ››

BOZEMAN, Mont., Aug. 12, 2020 /PRNewswire/ -- Golden Helix has secured its reputation as a global leader in Next-Generation Sequencing solutions for over two decades. Today, they have been included in the esteemed Inc. 5000 list of rapidly growing American companies. Out of the 6 million business... Read more ››

OAKVILLE, ON, Aug. 12, 2020 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or the "Company") announced today that it has filed, and the Toronto Stock Exchange (the "TSX") has accepted, a Notice of Intention to Make a Normal Course Issuer Bid (the "Notice").

CALGARY, AB, Aug. 12, 2020 /CNW/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQX: CANSF) has released its financial and operating results for the three and six months ended June 30, 2020, reporting significant advancement in its operations and... Read more ››

TORONTO, Aug. 12, 2020 /CNW/ - Akumin Inc. (TSX: AKU.U) (TSX: AKU) ("Akumin" or the "Corporation") announced today its financial results for the quarter ended June 30, 2020 ("Q2 Fiscal 2020").